Many of our most promising technologies lack the attention and commercial support needed to make the leap from the lab to the market. Without that support, some potential breakthroughs may never materialize, depriving us of what could have been the next significant discovery.

Dr. Ryan Mehl and his team at Oregon State University were developing genetic code expansion (GCE) technology that showed promising applications across industry and academia, but lacked the necessary business and commercial support to take their work to the next level.

That’s where we saw an opportunity to help.

• The challenge: While the technology itself was well-developed, the research team lacked the knowledge and experience to transition from academic innovation to a commercial venture. They faced hurdles in developing a concrete business strategy that would support research and development in new spaces and applications.
• The approach: Our team supported Dr. Mehl by establishing a dual-path research approach that led to the formation of the GCE4All Center, a dedicated institute at Oregon State University, to continue research while bridging into commercialization on the startup side.
• The impact: By connecting Dr. Mehl with the professional and strategic foundation needed to transition to commercialization, NobleReach positioned the team to advance its GCE research and explore new focus areas. The startup now has the foundation and experience to support commercialization that did not previously exist and had strained efforts to maximize the technology’s potential.

The challenges this team faced serve as a reminder that overcoming setbacks can be much less intimidating with the right tools and support. While the process to get there requires conversation, collaboration, and risks, the results are rewarding in the end.

Listen to the audio version of this case study here.